Status message

Active context: kki_bg_colors_yellow

Rapamycin for Autism Phenotype & seizures in Tuberous Sclerosis (RAPS)

Principal Investigator:
Tanjala
Gipson

Tuberous sclerosis complex (TSC) is associated with autism and seizures. Recent studies in animals using rapamycin have shown cognitive improvement. Human studies have demonstrated a reduction in tumor burden, subjective cognitive improvement, and decreased seizure frequency. We plan to examine the ability of rapamycin to reduce the symptoms of autism, decrease seizure frequency, and improve cognition in patients affected by TSC.

Bradley L. Schlaggar, M.D., Ph.D., Named President and CEO of Kennedy Krieger Institute

We’re thrilled to welcome Bradley L. Schlaggar, M.D., Ph.D., to the Kennedy Krieger family as our next President and CEO.
Learn more.

Publications

Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.